ArticleCells2020

Targeting BC200/miR218-5p Signaling Axis for Overcoming Temozolomide Resistance and Suppressing Glioma Stemness.

Yu-Kai Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.